HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:

Obama Wants FDA’s “Full Review” As Recall Of Peanut Butter Items Goes On

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

FDA is due for a "full review" in light of a salmonella outbreak that has sickened more than 500 people, possibly killed eight, and prompted a massive recall of peanut butter products, according to President Obama
Table

View full table

Advertisement

Related Content

HBW Insight
FDA Stings Beehive Botanicals For Web Links That "Fell Through The Cracks"
HBW Insight
FDA Stings Beehive Botanicals For Web Links That "Fell Through The Cracks"
HBW Insight
CFSAN Gets Boost In 2010 Budget To Keep Up With Cosmetics Industry Growth
HBW Insight
Idea Of Dividing Food, Drugs At HHS Raises Question: What About Cosmetics?
HBW Insight
Hamburg/Sharfstein Appointments Do Not Signal Split Duties At FDA
HBW Insight
FDA Public Workshop To Gain Insight Into Profit-Motivated Adulteration
HBW Insight
Nominations To Lead FDA Coming Soon For Hamburg And Sharfstein
HBW Insight
Hamburg Joins Sharfstein On FDA Commissioner Shortlist
HBW Insight
Lawyers Urge Firms To Be Ready For Nanotech Torts, Tougher Inspections
HBW Insight
FDA Globalization Act of 2009
Advertisement
Tags:
UsernamePublicRestriction

Register

RS015952

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By